A clinical and health-economic evaluation of pulmonary vein encircling ablation compared with antiarrhythmic drug treatment in patients with persistent atrial fibrillation (Catheter Ablation for the Cure of Atrial Fibrillation-2 study)

Europace

Volumn 9, Issue 3, 2007, Pages 182-185

  Bertaglia, Emanuele ^a   Stabile, Giuseppe ^b   Senatore, Gaetano ^a   Colella, Andrea ^c   Del Greco, Maurizio ^d   Goessinger, Heinz ^e   Lamberti, Filippo ^f   Lowe, Martin ^g   Mantovan, Roberto ^h   Peters, Nicholas ⁱ   Pratola, Claudio ^j   Raatikainen, Pekka ^k   Turco, Pietro ^l   Verlato, Roberto ^m  

^a Ospedale Civile   (Italy)

^b Casa di Cura San Michele   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d SANTA CHIARA HOSPITAL   (Italy)

^e UNIVERSITY OF VIENNA   (Austria)

^f MOLINETTE HOSPITAL   (Italy)

^g UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^h OSPEDALE CA FONCELLO   (Italy)

ⁱ ST MARY S HOSPITAL   (United Kingdom)

^j Ospedale Sant'Anna di Cona   (Italy)

^k UNIVERSITY OF OULU   (Finland)

^l MARIA CECILIA HOSPITAL   (Italy)

^m Ospedale Civile Cosma   (Italy)

more..

Author keywords

Atrial fibrillation; Catheter ablation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ADULT; AGED; ARTICLE; AUSTRIA; CARDIOVERSION; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; FINLAND; FOLLOW UP; HEALTH ECONOMICS; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; HUMAN; ITALY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RELAPSE; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT PLANNING; UNITED KINGDOM;

ADULT; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COST-BENEFIT ANALYSIS; HUMANS; MIDDLE AGED; PULMONARY VEINS; RECURRENCE; RESEARCH DESIGN;

EID: 33947119251     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum004     Document Type: Article

References (25)

1. Ostrander LD Jr, Brandt RF, Kjelsberg MO, Epstein FH. Electrocardiographic finding among the adult population of a total natural community: Tecumseh, Michigan. Circulation 1965;31:888-98.
2. Kannel WB, Abbot RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982;306:1018-22.
3. Fuchs T, Podrid PJ: Pharmacological therapy for revision of atrial fibrillation and maintenance of sinus rhythm. In: Falk RH, Podrid PJ, eds. Atrial Fibrillation: Mechanism and Management. New York: Raven Press; 1992. 253-4.
4. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): a randomized trial. Lancet 2000;356:1789-94.
5. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347: 1825-33.
6. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.
7. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Mahé I, Bergmann JF. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation. Arch Intern Med 2006;166:719-28.
8. Corley SD, Epstein AE, Di Marco JP, Domanski MJ, Geller N, Greene HL et al. Relationship between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004;109:1509-13.
9. Cox JL, Boineau JP, Schuessler RB, Kater KM, Lappas DG. Five-year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 1993;56:814-24.
10. Cox JL, Schluesser RB, Lappas DG, Boineau JP. An 81/2 year experience with surgery of atrial fibrillation. Ann Surg 1996;224:267-73.
11. Haïssaguerre M, Gencel L, Fisher B, Le Metayer P, Poquet F, Marcus FI et al. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1994;5:1045-52.
12. Haïssaguerre M, Jaïs P, Shah DC, Gencel L, Pradeau V, Garrigue S et al. Right and left atrial radiofrequency catheter ablation therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1996;7:1132-44.
13. Gaita F, Riccardi R, Calò L, Scaglione M, Garberoglio L, Antolini R et al. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Circulation 1998;97:2136-45.
14. Pappone C, Oreto G, Lamberti F, Vicedomini G, Loricchio ML, Shpun S et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999;100:1203-8.
15. Ernst S, Schlutter M, Ouyang F, Khanedani A, Cappato R, Hebe J et al. Modification of the substrate for maintenance of idiopathic human atrial fibrillation: Efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation 1999;100:2085-92.
16. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
17. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological response, and effects of radiofrequency ablation. Circulation 1999;100:1879-86.
18. Pappone C, Rosanio, S, Oreto G, Tocchhi M, Gugliotta F, Vicedomini G et al. Circumferential radiofrequency ablation of pulmonary vein ostia. Circulation 2000;102:2619-28.
19. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation. J Am Coll Cardiol 2003;42:185-97.
20. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: A prospective, multicentre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). Eur Heart J 2006;27:216-21.
21. Oral, H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006;354:934-41.
22. Levy S, Camm AJ, Saksena S, Aliot E, Breithardt G, Crijns HJ et al. International consensus on nomenclature and classification of atrial fibrillation: A collaborative project of the working group on arrhythmias and the working group on cardiac pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 2003;14:443-5.
23. Oral H, Scharf C, Chugh A, Hall B, Cheung P, Good E et al. Catheter ablation for paroxysmal atrial fibrillation. Segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003;108:2355-60.
24. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-5.
25. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW et al. Atrial fibrillation management: A prospective survey in ESC Member Countries. The Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005;26:2422-34.